Rapamycin is a drug known to prevent the rejection of organ transplant, and it’s also known as Sirolimus. The medicine treats sporadic lung disease, and it is used for coating the coronary stents. Rapamycin known by the trade name Rapamune in the pharmacy is famously known as a cancer drug. The drug was an isolated medium and introduced to the world in the year 1972 when the bacterium samples were found in Easter Island and used as the Anti-fungal agent. Later the drug was discovered to contain high levels of antiproliferative and immunosuppressive properties. Mikhail Blagosklonny is a well-distinguished Oncology situated at Buffalo, Newyork Rosewell Park Cancer Institute. Over the years, he has done numerous researchers on therapies and cancers. Mikhail has played an essential role as the Oncotarget editor-in-chief. He has done research and published broad information on aging. Mikhail encourages the use of Rapamycin to increase human being lifespan and his well-researched contribution towards aging is unparallel and immense.
According to Dr. Mikhail Blagosklonny, numerous researchers on Rapamycin in different animals like aging Mice have shown much ability of the mice dealing with tuberculosis. Rapamycin when administered in human and especially elderly patients before influenza vaccination has demonstrated immunological rejuvenation. Dr. Blagosklonny believes that the drug can increase the longevity of human. He states that Rapamycin antiproliferative properties are essential when it comes to treating cancer patients. The drug has a capacity of enhancing the patient immune response towards tumors, and it promotes tumor regression. Dr. Mikhail says that Rapamycin has numerous utility when it comes to reducing cancer risks and primarily on patients with an organ transplant.
Mikhail Blagosklonny is a professor, philanthropist and a professor. He is average people who believe in equal treatment for all people regardless of their economic standings. Dr. Mikhail is interested in medical research mostly in aging and cancer. Mikhail Blagosklonny thinks that there is a connection between aging and disease. He has continued to conduct his research on oncology field where he will plan on getting a concrete answer on preventing aging. Mikhail is quite an influential person as a researcher as well as a professor. In the area of oncology, Mikhail is admired by his students and peers who follow all his research keenly. His students believe in his studies, and they plan on expanding oncology research in the future.
The Mikhail topic on aging and cancer has drawn attention from medical fields on impact journals. His primary goal of coming up with ways to treat disease more efficiently. He plans on medication that is not expensive and excruciating. Dr. Mikhail believes that he will come up with a treatment that can eliminate cancerous cells without interfering with healthy cells. According to Mikhail, healthy cells are essential in recovering of the body and mind after countless months of cancer treatment. Mikhail progress on oncology has brought up hope for many people around the world. He believes in getting a simple treatment for this tragic and dangerous cancer disease without having to use a lot of money.